Terms: = Cervical cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1
123 results:
1. Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer.
Eiro N; Fraile M; Escudero-Cernuda S; Sendon-Lago J; Gonzalez LO; Fernandez-Sánchez ML; Vizoso FJ
Stem Cell Res Ther; 2024 Apr; 15(1):121. PubMed ID: 38664697
[TBL] [Abstract] [Full Text] [Related]
2. Parabens promotes invasive properties of multiple human cells: A potential cancer-associated adverse outcome pathway.
Wang L; Chen L; Schlenk D; Li F; Liu J
Sci Total Environ; 2024 May; 926():172015. PubMed ID: 38547973
[TBL] [Abstract] [Full Text] [Related]
3. Delayed cervical cancer diagnosis: a systematic review.
Allahqoli L; Dehdari T; Rahmani A; Fallahi A; Gharacheh M; Hajinasab N; Salehiniya H; Alkatout I
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8467-8480. PubMed ID: 36459029
[TBL] [Abstract] [Full Text] [Related]
4. Human Papillomavirus Modulates Matrix Metalloproteinases During Carcinogenesis: Clinical Significance and Role of Viral Oncoproteins.
Mendonça F; Teles AM; Nascimento MDDSB; Santos APAD; Lopes FF; Paiva A; Brito HO; DA Costa RG
In Vivo; 2022; 36(6):2531-2541. PubMed ID: 36309355
[TBL] [Abstract] [Full Text] [Related]
5. Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan.
Chung JF; Chen CL; Nassef Y; Shiu BH; Wang CH; Kuo FH; Hsiao YH; Yang SF; Wang PH
Int J Med Sci; 2022; 19(6):1013-1022. PubMed ID: 35813301
[TBL] [Abstract] [Full Text] [Related]
6. Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells.
Li X; Zhao J; Yan T; Mu J; Lin Y; Chen J; Deng H; Meng X
J Food Sci; 2021 Jun; 86(6):2700-2712. PubMed ID: 33908630
[TBL] [Abstract] [Full Text] [Related]
7. CD24 gene inhibition and timp-4 gene upregulation by Imperata cylindrica's root extract prevents metastasis of CaSki cells via inhibiting PI3K/Akt/snail signaling pathway and blocking EMT.
Nayim P; Mbaveng AT; Sanjukta M; Rikesh J; Kuete V; Sudhir K
J Ethnopharmacol; 2021 Jul; 275():114111. PubMed ID: 33848610
[TBL] [Abstract] [Full Text] [Related]
8. The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer.
Xu L; Li C; Hua F; Liu X
Med Oncol; 2021 Apr; 38(5):58. PubMed ID: 33847822
[TBL] [Abstract] [Full Text] [Related]
9. HIV Protease Inhibitors Block HPV16-Induced Murine cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and timp-3 Induction.
Qiu Y; Maione F; Capano S; Meda C; Picconi O; Brundu S; Pisacane A; Sapino A; Palladino C; Barillari G; Monini P; Bussolino F; Ensoli B; Sgadari C; Giraudo E
Mol Cancer Ther; 2020 Dec; 19(12):2476-2489. PubMed ID: 33082275
[TBL] [Abstract] [Full Text] [Related]
10. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, timp-1, timp-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
[TBL] [Abstract] [Full Text] [Related]
11. Expressions of extracellular matrix-remodeling factors in lymph nodes from oral cancer patients.
Fujita S; Sumi M; Tatsukawa E; Nagano K; Katase N
Oral Dis; 2020 Oct; 26(7):1424-1431. PubMed ID: 32419185
[TBL] [Abstract] [Full Text] [Related]
12. Plasma Levels and Tissue Expression of Selected Cytokines, Metalloproteinases and Tissue Inhibitors in Patients With cervical cancer.
Sidorkiewicz I; Piskór B; Dąbrowska E; Guzińska-Ustymowicz K; Pryczynicz A; Zbucka-Krętowska M; Ławicki S
Anticancer Res; 2019 Nov; 39(11):6403-6412. PubMed ID: 31704874
[TBL] [Abstract] [Full Text] [Related]
13. Role of matrix metalloproteinases and their inhibitors in the development of cervical metastases in papillary thyroid cancer.
Bumber B; Marjanovic Kavanagh M; Jakovcevic A; Sincic N; Prstacic R; Prgomet D
Clin Otolaryngol; 2020 Jan; 45(1):55-62. PubMed ID: 31646745
[TBL] [Abstract] [Full Text] [Related]
14. Vasculogenic Mimicry Formation Is Associated with Erythropoietin Expression but Not with Erythropoietin Receptor Expression in cervical Squamous Cell Carcinoma.
Li YJ; Qing X; Tao QX; Xiang L; Gong L; Zhou TJ
Biomed Res Int; 2019; 2019():1934195. PubMed ID: 30915348
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (timp-2) in cervical cancer Patients Based on ROC Analysis.
Lubowicka E; Zbucka-Kretowska M; Sidorkiewicz I; Zajkowska M; Gacuta E; Puchnarewicz A; Chrostek L; Szmitkowski M; Ławicki S
Pathol Oncol Res; 2020 Apr; 26(2):791-800. PubMed ID: 30820752
[TBL] [Abstract] [Full Text] [Related]
16. [Gelatinases A and B and their endogenous regulators in the corpus uteri in squamous cell cervical carcinoma].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
Arkh Patol; 2018; 80(6):22-28. PubMed ID: 30585589
[TBL] [Abstract] [Full Text] [Related]
17. Erythropoietin promotes expression of survivin via STAT3 activation and reduces sensitivity to cisplatin in cervical cancer cells.
Vázquez-Mellado MJ; Cortés-Ballinas LG; Blanco-Flores IC; Aguilar C; Vázquez-Gómez G; Rocha-Zavaleta L
Oncol Rep; 2019 Feb; 41(2):1333-1341. PubMed ID: 30483799
[TBL] [Abstract] [Full Text] [Related]
18. Synergistic Action of 1,2-epoxy-3 (3- (3,4-dimethoxyphenyl)- 4H-1-benzopiyran-4-on) Propane with Doxorubicin and Cisplatin through Increasing of p53, timp-3, and MicroRNA-34a in cervical cancer Cell Line (HeLa).
Yuniarti L; Mustofa M; Aryandono T; Haryana SM
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2955-2962. PubMed ID: 30362332
[TBL] [Abstract] [Full Text] [Related]
19. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of cervical cancer Based on ROC Analysis.
Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
[TBL] [Abstract] [Full Text] [Related]
20. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
Yuan Y; Ye HQ; Ren QC
Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
[TBL] [Abstract] [Full Text] [Related]
[Next]